Cint Trades the Squeeze, Not the Cash

Summary: CINT.ST was quoted at SEK 5.760 on the latest cached Stockholm-market close visible in this run, dated May 15, 2026. That is 2.9% above the live SEK 5.60 per share cash offer from TriCarbs BidCo. The board recommends the offer, the offer document is out, the acceptance period is live, and the bidder consortium already controls 34.0% of the company. The tape is still paying for optionality that the offer documents make structurally hard to realize. [1][2][3][4]

Opportunity Ranking

Rank	Idea	Discovery Lane	Why It May Be Best Now	Evidence Freshness	Catalyst Window	Asymmetry	Main Reason to Reject
1	Cint trades the squeeze, not the cash	Europe / Sweden / public cash offer / wrong-way spread	The stock still trades above a live SEK 5.60 cash offer even though the board recommends it and the consortium already controls a blocking stake.	Official board statement April 27, 2026; offer document publication May 13, 2026; quote page checked with May 15, 2026 close.	Acceptance period runs May 14 to June 12, 2026; expected settlement starts around June 22, 2026.	If the tape stops paying for a bump that the documents do not support, the stock can fall back to the offer or below.	Selected.
2	Shinko Shoji trades above Kaga's cash TOB	Japan / TOB / wrong-way spread	Kaga's tender is live at JPY 1,580, yet the stock still trades above the bid.	Kaga TOB release May 15, 2026; quote page checked May 18, 2026.	Tender runs through June 26, 2026.	A short case exists if the premium to the tender persists.	The quote evidence was noisier in this run, and the setup was less clean than Cint.
3	Expensify's Dutch auction is not a floor	U.S. / self-tender / Dutch auction	Expensify launched a $25 million self-tender, but the stock already trades inside the price range.	BusinessWire tender release May 13, 2026; quote snapshot checked May 18, 2026.	Tender expires June 10, 2026.	None of the economics force spot to one fixed number.	A floating Dutch-auction range is not a hard cash door.
4	Compal buyback range is not a cash exit	Broader Asia / Taiwan / buyback / open-market repurchase	The company has a stated buyback range, but holders still face ordinary open-market execution, not a fixed-price cash-out.	Board filing May 12, 2026; quote page checked May 18, 2026.	Buyback period runs through July 10, 2026.	Weak. The structure is supportive, not dispositive.	No fixed-price closing mechanism.

Selected opportunity: Cint Group AB (CINT.ST)

Why this one now: Unlike the U.S. and Asia screens, Cint offers a live, documented, board-recommended cash process. Unlike Japan's Shinko setup, the structural reason the stock should not trade rich is unusually explicit in the documents.

What should surprise the reader: The market still pays above cash even though the same documents that launched the offer also explain why a rival bidder would have difficulty ever reaching a Swedish squeeze-out threshold without the consortium's cooperation.

Geographic Search Audit

U.S. candidate screened: Expensify. Rejected because a Dutch-auction tender range is not a fixed-price floor.
Japan candidate screened: Shinko Shoji. Rejected because quote evidence was less stable and the setup was less compelling than Cint.
Broader Asia candidate screened: Compal. Rejected because an open-market buyback is not a hard exit price.
Europe / UK candidate screened: Cint. Selected.

The Setup

On April 27, 2026, a bid consortium made up of Triton Fund 6, Bolero, Patrick Comer, and Brett Schnittlich, acting through TriCarbs BidCo, offered SEK 5.60 in cash for each Cint share. Cint's board unanimously recommended acceptance and attached a fairness opinion from KPMG. [1]

On May 13, 2026, the bidder published the offer document. The acceptance period opened on May 14 and runs through June 12, 2026. Settlement for tenders submitted by the deadline is expected to start around June 22, 2026, assuming the conditions are satisfied or waived. [2]

The live operating backdrop is not a disaster story. Cint's Q1 2026 report showed net sales of EUR 34.0 million, EBITA of EUR 4.6 million, EBIT of EUR 0.8 million, and quarter-end net cash of EUR 10.2 million. Management described the quarter as verification that the Cint 2.0 plan is working. [3]

That matters because the short thesis cannot lazily assume that the business is imploding. It is not. The case is narrower: the tape is still too rich relative to the actual deal terms and the actual control map.

The Mispricing

The facts are straightforward.

The live offer is SEK 5.60 cash. [1][2]
The board recommends it and says the price is fair. [1]
The consortium already controls 34.0% of all outstanding shares. [1]
The bidder can waive the more-than-90% acceptance condition and still complete at a lower level. [1]
CINT.ST was quoted at SEK 5.760 on the latest visible close in this run. [4]

The inference is the trade.

At SEK 5.760, the market is paying SEK 0.160, or about 2.9%, above the only documented cash number. That premium only makes sense if investors think one of three things is likely:

the bidder will raise the price,
a rival bidder will emerge with a superior path, or
the standalone company is worth clearly more than SEK 5.60 in the near term and holdouts will be rewarded for not tendering.

The documents push against all three.

Price

The current price map is simple.

Metric	Reading	Why It Matters
`CINT.ST` last visible close	SEK 5.760	The tape used for this run
Live offer price	SEK 5.60	The only documented cash consideration
Premium to offer	SEK 0.160 / 2.9%	The stock trades above cash
Unaffected close on April 24, 2026	SEK 4.21	The offer started as a 33% premium
30-day VWAP before the offer	SEK 3.97	Offer premium was 41.0%
60-day VWAP before the offer	SEK 3.40	Offer premium was 64.6%
90-day VWAP before the offer	SEK 3.26	Offer premium was 72.0%

The point is not that SEK 5.60 was stingy on day one. The point is that the tape is now richer than the live offer even after the board endorsed it and even after the bidder published the offer document.

Positioning

The positioning evidence is not a borrow dataset. It is the ownership map.

According to the board statement, the consortium already controls 34.0% of all outstanding shares. Bolero alone holds more than 10%. The board then states the load-bearing fact plainly: a competing bidder that wants a traditional Swedish squeeze-out above 90% would need an agreement with the consortium regarding those shares. [1]

That makes the premium above SEK 5.60 harder to defend.

This is not a wide-open auction. It is a company where the bidder group already holds the blocking paper that a rival would need in order to finish the job cleanly.

The board also highlights a second tension. Because the bidder can waive the 90% condition, holdouts who refuse the offer may simply end up owning a much thinner public float in a company where the bidder has very large influence but not full ownership. [1]

That weakens the usual "stay long for the bump" logic. A holdout is not obviously long a better bid. A holdout may just be long illiquidity.

What I could not safely verify in this run: live stock-loan cost and exchange-listed options liquidity. Those are execution questions, not thesis pillars, and they remain explicitly uncertain.

Catalyst

This setup has a visible clock.

The offer document is published. [2]
The acceptance period is live through June 12, 2026. [2]
Settlement is expected to begin around June 22, 2026. [2]
Every day that passes without an improved offer forces the tape to confront the same stubborn fact: the live cash number is still SEK 5.60.

There is also a negative catalyst hiding inside the structure. If no bump appears and investors stop treating the stock as a quasi-auction, the price does not need to fall all the way back to SEK 4.21 to hurt longs. It only has to stop trading above the live offer.

Payoff Map

The cleanest expression is short CINT.ST common stock only if borrow is available at a tolerable cost.

This is not an options-first idea. I did not safely verify a live listed options chain with enough liquidity to underwrite a specific structure. Fabricating one would be fake precision.

The first target is the obvious one: SEK 5.60, the live cash offer. The more interesting tail is lower than that. If the offer weakens, is waived at a low take-up, or the market stops capitalizing takeover optionality, the stock can trade back toward a standalone frame. The unaffected close was SEK 4.21 on April 24. [1]

That does not mean SEK 4.21 is the required outcome. It does mean the downside below SEK 5.60 is real, while the upside above SEK 5.60 still requires evidence that the documents do not yet provide.

Price Target and Probability Map

Scenario	Probability	Target / Level	Return / Payoff	Time Horizon	Conditions Required	Evidence Quality
Top Case	15%	SEK 6.00	+4.2%	1 to 6 weeks	The bidder improves terms, or a rival emerges with consortium support that turns the process into a real price competition.	Low-Medium
Base Case	50%	SEK 5.60	-2.8%	1 to 4 weeks	No improved offer appears and the stock converges to the live cash number during the acceptance period.	High
Bottom Case	35%	SEK 4.60	-20.1%	2 to 10 weeks	The deal loses momentum, closes in a way that leaves an illiquid residual equity, or the market reprices Cint closer to standalone risk.	Medium
Invalidation / Stop Condition	n/a	Sustained trade above SEK 5.95 on documented improved terms	Thesis broken	Immediate once visible	A real price increase or consortium-backed superior path invalidates the short.	High

Probability-weighted expected value: SEK 5.31, or about -7.8% versus the current tape.

Current market price / level: CINT.ST SEK 5.760

Timestamp: Latest visible close in this run, dated May 15, 2026

Primary instrument: CINT.ST common stock

Alternative expressions considered: Options rejected due insufficient live verification; avoiding the trade remains valid if borrow is unavailable or punitive

Confidence: Medium

What Would Prove This Wrong

Three facts would break the thesis.

The bidder raises the offer above the current market.
A superior bidder emerges with a path that the consortium is actually willing to support.
Borrow cost or stock-loan scarcity becomes so hostile that the trade expression is worse than the valuation call is good.

A generic sell-side note about Cint 2.0 is not invalidation. A filed or documented change in deal terms is.

Risk Audit

Strongest counterargument: Cint 2.0 is finally showing signs of life, media measurement is accelerating, and the bidder may need to pay a small bump to avoid being stuck with a messy partial outcome below 90%.

Most fragile assumption: That the consortium will prefer deal certainty at SEK 5.60 over a modest sweetener that cleans up the shareholder register.

What the market may already know: Some merger-arb capital may be paying above cash because it believes the bidder cannot tolerate a long-lived listed stub.

What could make the trade lose money even if the thesis is directionally right: Borrow cost, illiquidity, and a slow grind where the stock stays rich until very late in the offer window.

Liquidity / execution risks: Swedish small-cap liquidity and short availability were not fully verified in this run.

Leverage risks: High if expressed with leverage. This idea does not need leverage.

Information reliability risks: Low on the offer terms and board recommendation, moderate on real-time execution variables such as borrow and options.

Invalidation trigger: A documented improved offer, or a consortium-supported superior path.

Publish / revise / reject recommendation: Publish.

Bottom Line

The market is trading Cint as if the current offer were just a placeholder.

The documents say otherwise. The board recommends SEK 5.60. The offer document is out. The acceptance period is live. The consortium already controls 34.0% of the company, and the board itself explains why a competing bidder would have difficulty reaching a clean squeeze-out without consortium cooperation. Against that backdrop, SEK 5.760 is not the price of the documented deal. It is the price of hope for a better one. Until the filings change, that extra hope looks overpriced.

Research Quality Scorecard

The full scorecard is kept in the companion meta file.

Sources

Best Trade Strategy

Best trade: Short CINT.ST common stock if borrow is available at an acceptable cost. If borrow is not clean, the right answer is avoid. Options were not safely verified in this run.